---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009075"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T13:59:29.493165+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharmaceuticals provides unaudited balance sheet as of Jan 31, 2025; cash of $5.36M

## Summary
- Cash and cash equivalents of $5.36M as of January 31, 2025.
- Total assets of $6.5M, total liabilities of $0.55M.
- Stockholders' equity of $5.95M, accumulated deficit of $238M.
- No revenue or operational update provided; balance sheet only.

## SEC filing metadata
- accession: 0001493152-25-009075
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/0001493152-25-009075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009075
- JSON: https://secwatch.observer/filing/0001493152-25-009075.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.